PHARMACY

Indivior gets FDA nod for Perseris
Indivior’s once-monthly Perseris now offers a new option for treating adults with schizophrenia.
Hikma unveils generic Halcion
Hikma is introducing generic Halcion, which had a market value of about $27 million for the year ended September 2018, according to IQVIA data.

FDA clears new indication for Promacta

The FDA's approval for a new indication for Promacta provides a new treatment for a rare life-threatening disease.
Walgreens debuts ‘Feel More Like You’ program

The “Feel More Like You” program is meant to help patients with cancer and their caregivers manage the physical effects of undergoing cancer treatment.
Nexus gets FDA nod for generic Trisenox

Nexus is offering a generic version of Teva's Trisenox for intravenous use in leukemia patients.
FDA clears new indication for Adcetris

Seattle Genetics' Adcetris injection (brentuximab vedotin) has received the FDA's nod to be used in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.
Glenmark gets FDA's blessing for generic Aubagio

Glenmark Pharmaceuticals has received the FDA's OK for generic Aubagio, which had a market value of about $1.6 billion for the year ended September 2018, according to IQVIA.
FamilyWize updates prescription discount mobile app

FamilyWize said its enhanced mobile app optimizes the user experience with customizable features to find the lowest cost prescription prices.
Pharmacist-administered immunization opportunities are expanding

The National Community Pharmacist Association’s John Beckner writes that pharmacists can continue to play a pivotal role in administering immunizations and improving patient health
PQA partnership will create rubric for patient-centered quality measurement

The Pharmacy Quality Alliance is collaborating with NHC and NQF to create a patient-engagement rubric specific to quality measurement.